Form 4: Guardant Health Director Steve Krognes Reports Stock Transactions
SEC Form 4 Filing
Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.
Summary
- On March 31, 2025, Steve Krognes, a director of Guardant Health, Inc., reported transactions involving the company's stock.
- Krognes converted 154 restricted stock units into 154 shares of common stock.
- The price per share for the conversion was $0.
- Following the transaction, Krognes directly owns 10,682 shares of common stock and 2,315 restricted stock units.
- The restricted stock units were part of an award granted on August 9, 2022, which vests in installments.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company insiders.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 08/09/2022 | Date of restricted stock unit award grant. |
| 06/30/2023 | Initial vesting date of the restricted stock unit award. |
| 03/31/2025 | Date of the reported transaction (conversion of restricted stock units). |
| 04/02/2025 | Date of signature on the Form 4 filing. |
Keywords
Guardant Health, Krognes, Stock, Restricted Stock Units, Form 4, Director, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.